These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 37885889)
1. MAIT cells altered phenotype and cytotoxicity in lupus patients are linked to renal disease severity and outcome. Litvinova E; Bounaix C; Hanouna G; Da Silva J; Noailles L; Beaudoin L; Padden M; Bellamri N; Lehuen A; Daugas E; Monteiro RC; Flament H Front Immunol; 2023; 14():1205405. PubMed ID: 37885889 [TBL] [Abstract][Full Text] [Related]
2. Activation status of mucosal-associated invariant T cells reflects disease activity and pathology of systemic lupus erythematosus. Chiba A; Tamura N; Yoshikiyo K; Murayama G; Kitagaichi M; Yamaji K; Takasaki Y; Miyake S Arthritis Res Ther; 2017 Mar; 19(1):58. PubMed ID: 28288675 [TBL] [Abstract][Full Text] [Related]
3. Increased pathogenicity and pro-inflammatory capabilities of mucosal-associated invariant T cells involved in Oral Lichen Planus. Chen S; Wu X; Yang Y; Xu X; Xiong X; Meng W BMC Oral Health; 2024 Jul; 24(1):829. PubMed ID: 39039547 [TBL] [Abstract][Full Text] [Related]
4. A Critical Role for Mucosal-Associated Invariant T Cells as Regulators and Therapeutic Targets in Systemic Lupus Erythematosus. Murayama G; Chiba A; Suzuki H; Nomura A; Mizuno T; Kuga T; Nakamura S; Amano H; Hirose S; Yamaji K; Suzuki Y; Tamura N; Miyake S Front Immunol; 2019; 10():2681. PubMed ID: 31849932 [TBL] [Abstract][Full Text] [Related]
5. MAIT cell alterations in adults with recent-onset and long-term type 1 diabetes. Nel I; Beaudoin L; Gouda Z; Rousseau C; Soulard P; Rouland M; Bertrand L; Boitard C; Larger E; Lehuen A Diabetologia; 2021 Oct; 64(10):2306-2321. PubMed ID: 34350463 [TBL] [Abstract][Full Text] [Related]
6. Persistent deficiency of mucosal-associated invariant T cells during dermatomyositis. Cassius C; Branchtein M; Battistella M; Amode R; Lepelletier C; Jachiet M; de Masson A; Frumholtz L; Chasset F; Amoura Z; Mathian A; Samri A; Monfort JB; Bachmeyer C; Bengoufa D; Cordoliani F; Bagot M; Bensussan A; Bouaziz JD; Le Buanec H Rheumatology (Oxford); 2020 Sep; 59(9):2282-2286. PubMed ID: 31846040 [TBL] [Abstract][Full Text] [Related]
7. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus. Cho YN; Kee SJ; Kim TJ; Jin HM; Kim MJ; Jung HJ; Park KJ; Lee SJ; Lee SS; Kwon YS; Kee HJ; Kim N; Park YW J Immunol; 2014 Oct; 193(8):3891-901. PubMed ID: 25225673 [TBL] [Abstract][Full Text] [Related]
9. Human liver CD8 Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824 [TBL] [Abstract][Full Text] [Related]
10. Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients. Wang H; Lan L; Chen J; Xiao L; Han F Lupus Sci Med; 2022 Aug; 9(1):. PubMed ID: 35973743 [TBL] [Abstract][Full Text] [Related]
11. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis. Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A Front Immunol; 2020; 11():256. PubMed ID: 32265898 [TBL] [Abstract][Full Text] [Related]
12. Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease. Juno JA; Waruk JLM; Wragg KM; Mesa C; Lopez C; Bueti J; Kent SJ; Ball TB; Kiazyk SA Front Immunol; 2018; 9():1076. PubMed ID: 29868028 [TBL] [Abstract][Full Text] [Related]
14. IL-21 dependent Granzyme B production of B-cells is decreased in patients with lupus nephritis. Rabani M; Wilde B; Hübbers K; Xu S; Kribben A; Witzke O; Dolff S Clin Immunol; 2018 Mar; 188():45-51. PubMed ID: 29274388 [TBL] [Abstract][Full Text] [Related]
15. Mucosal-associated invariant T cell alterations during the development of human type 1 diabetes. Gazali AM; Schroderus AM; Näntö-Salonen K; Rintamäki R; Pihlajamäki J; Knip M; Veijola R; Toppari J; Ilonen J; Kinnunen T Diabetologia; 2020 Nov; 63(11):2396-2409. PubMed ID: 32880687 [TBL] [Abstract][Full Text] [Related]
16. Mucosal-associated invariant T cells from Clostridioides difficile-infected patients exhibit a distinct proinflammatory phenotype and enhanced cytotoxic activity. Brauns S; Marquardt I; Thon C; Frentzel S; Jakob J; Färber J; Philipsen L; Jänsch L; Link A; Bruder D Int Immunol; 2023 Nov; 35(11):543-554. PubMed ID: 37549964 [TBL] [Abstract][Full Text] [Related]
17. Mucosal-associated invariant T cells in patients with axial spondyloarthritis. van der Meer RG; Spoorenberg A; Brouwer E; Doornbos-van der Meer B; Boots AMH; Arends S; Abdulahad WH Front Immunol; 2023; 14():1128270. PubMed ID: 36969157 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features and outcomes of SLE patients with renal injury characterised by thrombotic microangiopathy. Chen W; Liang S; Zuo K; Yang L; Zeng C; Hu W Clin Rheumatol; 2021 Jul; 40(7):2735-2743. PubMed ID: 33543375 [TBL] [Abstract][Full Text] [Related]
20. Proteomic definition of human mucosal-associated invariant T cells determines their unique molecular effector phenotype. Bulitta B; Zuschratter W; Bernal I; Bruder D; Klawonn F; von Bergen M; Garritsen HSP; Jänsch L Eur J Immunol; 2018 Aug; 48(8):1336-1349. PubMed ID: 29749611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]